Key Points for Laboratory Selection, Quality Control, and Storage Management of Commonly Used Biological Reagents

Main Categories and Common Applications of Common Biological Reagents

Common biological reagents generally refer to buffers, enzymes, nucleic acid and protein labels, antibodies, culture media, and general detection substrates that are frequently used in experimental and production processes such as molecular biology, cell biology, immunology, and in vitro diagnostics. Different experimental purposes have different requirements for reagent grade and formulation. For example, lysis buffers, wash buffers, Taq DNA polymerase, dNTP mixtures, and nucleic acid dyes are commonly used in nucleic acid extraction and amplification experiments; blocking solutions, wash solutions, enzyme-labeled secondary antibodies, and chromogenic substrates are commonly used in immunoassays; basal media, serum replacements, trypsin digestion solutions, and antibiotic mixtures are commonly used in cell culture. Although these reagents are used frequently, batch-to-batch differences, storage conditions, and operating habits may all affect result reproducibility. Therefore, unified standards need to be established for selection and routine management.

Core Indicators and Documents to Consider During Selection

When purchasing common biological reagents, in addition to packaging specifications and price, more attention should be paid to quality indicators and document completeness. Suppliers are generally required to provide a certificate of analysis (COA), safety data sheet (SDS), and basic performance description. For enzyme reagents, attention may be paid to the definition of enzyme activity units, purity description, and nuclease residue; for antibodies, attention may be paid to applicable experimental types, recommended dilution ranges, and batch-to-batch consistency statements; for buffers and culture media, attention may be paid to pH range, osmolality, endotoxin level, and sterility assurance method. Common specifications usually include small trial packages, medium packages, and industrial bulk packages. Laboratories should choose appropriate packaging based on monthly usage to avoid performance degradation caused by repeated freeze-thaw cycles or long-term opening.

Check whether the reagent name, purity grade, and storage temperature match the experimental requirements;

Review key performance indicators in the COA, such as enzyme activity, pH, and endotoxin;

Confirm whether Chinese labels and compliant SDS are provided;

Give priority to suppliers with stable supply and timely document updates.

General Requirements for Storage, Requisition, and Batch Management

Common biological reagents are relatively sensitive to temperature, humidity, and light. In general requirements, conventional PCR reagents and antibodies are recommended to be aliquoted and stored at -20°C or -80°C; culture media and some buffers can be refrigerated at 2-8°C, but repeated warming should be avoided. Laboratories can establish reagent requisition registration and opening date records, and implement aliquoting and freeze-thaw cycle control for easily degradable reagents. Different batches of reagents are recommended to undergo parallel verification in key experiments, recording lot number, expiration date, and performance. If a supplier or formulation version is changed, comparability testing should be carried out to ensure that result trends are traceable. Storage equipment should be regularly calibrated for temperature, and over-temperature alarms and backup power should be set up to reduce quality risks caused by equipment failure.

Notes on Compliant Use and Supplier Evaluation

Although common biological reagents are mostly general-purpose products, their compliant sources and boundaries of use still need attention in in vitro diagnostic or pharmaceutical R&D applications. Reagents intended only for research use must not be directly used in clinical diagnostic or therapeutic scenarios, and relevant documents should clearly indicate the intended use. When qualifying suppliers, laboratories can comprehensively examine the production quality management system, cold chain integrity during transportation, complaint response capability, and technical documentation support. For reagents involving animal-derived components or special biosafety risks, the pathogen inactivation method, source certification, and waste disposal requirements should also be evaluated. By establishing supplier scoring and regular review mechanisms, experimental differences caused by raw material batch fluctuations can be reduced, while biosafety and data reproducibility are ensured.